The Neuroendocrinology Program offers comprehensive diagnosis and treatment of endocrine disorders related to hypothalamic and pituitary region tumors, as well as the endocrine late effects of the treatments of other malignancies, hematologic disorders, and Neurofibromatosis-1. We work closely with clinicians from Boston Children's Hospital and Dana-Farber Cancer Institute in the Cancer and Blood Disorders Center, Neurofibromatosis Program, Department of Urology, and Division of Adolescent Medicine, as well as from the Type 2 Diabetes Mellitus and Thyroid Nodule Programs within the Division of Endocrinology, to provide comprehensive multidisciplinary care. An additional interest of the program is in growth hormone deficiency.
Reaching new heights
Fifteen-year-old twins Peter and Nicholas Campbell are short. As freshmen in high school, they stand at 4 feet 2 inches each. But with a mother who is 5 feet 5 inches, a father who is 5 feet 8 inches, and no additional underlying conditions that might affect their growth, the reason for their below-average height is yet unknown.
Laurie Cohen, MD, director of the Neuroendocrinology Program at Boston Children's Hospital, has diagnosed the boys with Idiopathic Short Stature (ISS), a condition in which a child doesn't grow to a height that is within the normal range, despite physical makeup and laboratory tests being normal.
Read more of Peter and Nicholas' story.
Q & A: Growth hormone deficiency
Short stature isn't an illness, but a child who is more than two standard deviations below the expected age-appropriate mean height needs to be assessed for what could be one of several possible underlying conditions.
Laurie Cohen, MD discusses growth hormone deficiency (GHD), one possible cause for short stature. Read more.